United States · 
Who invested in Bluejay Therapeutics?
Bluejay Therapeutics's investors include RA Capital Management, Wellington Management and Novo Holdings.
United States · Series C startup
Who invested in Bluejay Therapeutics
Funding summaryUpdated 26 Oct 2026
$182Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $182MMay 2024
- Investors
- 3
The rounds
- May 2024Series C$182M
Source recordedSEC filing: $182M sold, first sale May 2024
Founders and team
From the SEC filings it signed: 1 on the team.
- Keting ChuExecutive Officer, Directori
On the board, as filediAlon LazarusDajun YangDan EstesJianqing LiPascal Krotee
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Bluejay Therapeutics
How much has Bluejay Therapeutics raised?
Bluejay Therapeutics has raised $182M across 1 round since 2024.
When did Bluejay Therapeutics last raise?
Bluejay Therapeutics's most recent round was a Series C of $182M in May 2024.
What was Bluejay Therapeutics's biggest round?
Its most recent round, $182M in May 2024, is also its largest on record.
Who backed Bluejay Therapeutics first?
Bluejay Therapeutics's first round on record, in May 2024, was backed by RA Capital Management, Wellington Management and Novo Holdings.
What stage is Bluejay Therapeutics at?
Bluejay Therapeutics's latest named round is a Series C, in May 2024.
Where is Bluejay Therapeutics based?
Bluejay Therapeutics is based in the United States.
Companies like Bluejay Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.